Clinical trial
Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus…
NCT00002132 · Janssen Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00002132 |
|---|---|
| Title | Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis. |
| Official title | Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis. |
| Lead sponsor | Janssen Pharmaceuticals, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Candidiasis, Esophageal, HIV Infections |
| Intervention type | Drug |
| Interventions | Itraconazole, Fluconazole |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: